Sylvia Kornegay assists clients in shaping federal policy, appropriations and agency rulemaking. Her experience includes two decades of federal legislative work and she is dedicated to helping clients navigate the federal policy landscape and developing solutions that are impactful and values-based. Recognizing the importance of each organization’s specific mission and culture, she invests time in understanding the details of a client’s business and works to earn a place on the team. 

Sylvia advises corporate and nonprofit organizations, particularly in the health care sector, and has represented medical device manufacturers, pharmaceuticals, clinical laboratories and provider organizations. Her work includes legislative and executive branch campaigns involving drug pricing, Medicare payment systems and rulemaking before the Centers for Medicare & Medicaid Services and the Food and Drug Administration. She also works with providers to protect access to care for survivors of sexual assault and other forms of violence, including through the Violence Against Women Act. Sylvia’s in-depth experience and involvement with stakeholders across the health care ecosystem affords a holistic, comprehensive perspective to advocacy. Understanding that policymaking does not occur in a vacuum, she excels at critically analyzing political and legislative proposals, anticipating needs and changing environments and adapting strategies to meet client goals.

In addition to her health care experience, Sylvia has deep understanding of the federal budget and appropriations processes and knows how to appropriately develop and integrate funding strategies into government affairs initiatives. She also has worked with clients in higher education, consumer products, tax and financial services.

Prior to joining Polsinelli, Sylvia served as staff in the U.S. House of Representatives where she managed legislative portfolios including financial services, budget and small business issues; provided vote recommendations; handled appropriations requests; and drafted legislation, including a measure related to the Securities Investor Protection Corporation that became law.

Education

  • Boston University (B.A.)

    Professional Affiliations

    • Junior League of Northern Virginia
    Publications
    Beyond the Pump: The Iran War’s Adverse Impact on U.S. Health Care
    Key Takeaways The closure of the Strait of Hormuz following the U.S.-Iran conflict is disrupting global health care supply chains and increasing costs for critical medical products. Shortages and delays are already affecting pharmaceuticals, MRI-related helium supplies and cold-chain products. The disruptions create operational and financial pressure for health care providers that depend on imported drugs, medical equipment and time-sensitive supplies. Rising freight, fuel and insurance costs are contributing to higher prices and longer lead times across multiple product categories. Health care organizations should closely monitor supply availability, transportation delays and pricing volatility tied to the ongoing conflict and shipping restrictions. Providers may need to evaluate inventory levels, supplier diversification and contingency planning for critical medical inputs. Since the beginning of the United States’
    Read More
    Election Year Politics and Policy at CMMI: What Stakeholders Can Expect
    Key Takeaways CMS’ Innovation Center is accelerating new payment and care delivery models as the Trump administration uses CMMI to advance health policy priorities. Current models target areas such as chronic care, behavioral health, drug pricing and value-based care. CMMI remains a powerful policy vehicle, but its recent pace has drawn renewed scrutiny over cost savings, scale and taxpayer value. That debate could shape oversight, legislation and expectations for how future models are designed and evaluated. Health care stakeholders should continue tracking CMMI closely as participation opportunities expand and mandatory models create new operational demands. Organizations should assess where engagement, compliance planning or advocacy may be needed as models evolve. The Centers for Medicare & Medicaid Services (CMS) is currently pursuing approximately 35 models
    Read More